Financial Incentives + Nurse Coaching for Type 2 Diabetes
(FINANCE-DM Trial)
Trial Summary
What is the purpose of this trial?
The objective of this protocol is to answer the questions: 1) Are financial incentives layered upon nurse education and home telemonitoring superior to nurse education and home telemonitoring alone in improving metabolic control long term? 2) Are the effects of financial incentives on metabolic control sustained once the incentives are withdrawn? and 3) Are financial incentives efficacious within and consistent across racial/ethnic groups? This study provides a unique opportunity to address these gaps in the literature. Investigators propose a randomized controlled trial to test the efficacy of a Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM) intervention comprised of: 1) nurse education, 2) home telemonitoring, and 3) structured financial incentives; compared to an active control group (nurse education and home telemonitoring alone). The study also will evaluate whether intervention effects are sustained 6 months after the financial incentives are withdrawn (i.e. 18 months post randomization); and whether the intervention is differentially efficacious across racial/ethnic groups.
Research Team
Leonard Egede, MD
Principal Investigator
Medical College of Wisconsin
Eligibility Criteria
This trial is for adults over 21 with Type 2 Diabetes, specifically those who have not managed to control their blood sugar well (HbA1c >=8%). Participants must speak English, be willing to use a home monitoring system for a year, and have access to phone or internet. It's not open to those with life expectancies under 18 months, other diabetes trial participants, significant dementia, substance abuse issues, or acute mental disorders.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Active Comparator (Behavioral)
- FINANCE-DM (Behavioral)
Find a Clinic Near You
Who Is Running the Clinical Trial?
State University of New York at Buffalo
Lead Sponsor
Dr. Jonathan Slonin
State University of New York at Buffalo
Chief Medical Officer since 2020
MD from University of Miami, MBA from George Washington University
Stacy Knapper
State University of New York at Buffalo
Chief Executive Officer since 2023
BSEE from University of Puerto Rico-Mayagüez, MS in Management from Rensselaer Polytechnic Institute
Medical College of Wisconsin
Lead Sponsor
Dr. Joseph E. Kerschner
Medical College of Wisconsin
Chief Medical Officer since 2011
MD, specific institution not identified
Dr. John R. Raymond, Sr.
Medical College of Wisconsin
Chief Executive Officer since 2010
MD from the Medical University of South Carolina